not applicable (submitted trial is a bioequivalence study)

3 total trials 2 recruiting

Filter these 3 trials by phase, country, sponsor and more.

Open in Search →

A Phase I double blinded, single-center, randomized, crossover study comparing the PK, PD, safety and tolerability of a single IV dose (1µg/ … Recruiting

2024-518285-27-00 2 2025-12-01
A Phase I, randomized, consecutive dose, double blind, parallel study comparing the PK, PD, immunogenicity, safety and tolerability of LB-07 … Recruiting

2024-518286-95-00 2 2025-07-02
Open-label, randomized, two-treatment, two-period, two-sequence, cross-over, single dose, bioequivalence study comparing ISOPRINOSINE® FORTE … Ended

2024-514146-37-00 2 2024-10-24

Showing 1–3 of 3 trials